Is there a link between succinyl‑CoA:3‑oxoacid CoA‑transferase (SCOT) deficiency or transcobalamin‑II (T2) deficiency and anemia of chronic disease or iron‑deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No Direct Link Between SCOT or Transcobalamin-II Deficiency and Anemia of Chronic Disease or Iron-Deficiency Anemia

Neither SCOT (succinyl-CoA:3-oxoacid CoA transferase) deficiency nor transcobalamin-II (TC II) deficiency are associated with anemia of chronic disease or iron-deficiency anemia. These are distinct metabolic disorders with different hematologic manifestations.

SCOT Deficiency: No Anemia Association

SCOT deficiency is an autosomal recessive disorder of ketone body utilization caused by mutations in the OXCT1 gene. The clinical presentation is characterized by:

  • Recurrent episodes of severe ketoacidosis (not anemia) 1, 2, 3, 4
  • Typical onset between 6 months to 4 years of age (median 2 years) 3
  • Manifestations include respiratory distress, vomiting, lethargy, and potentially coma during metabolic crises 1
  • Normal psychomotor development in 92% of surviving patients with no chronic anemia reported 4

The comprehensive literature review of 44 patients with SCOT deficiency (34 previously published plus 10 novel cases) makes no mention of anemia as a clinical feature 4. The disorder affects ketone body metabolism, not iron metabolism or red blood cell production.

Transcobalamin-II Deficiency: Megaloblastic Anemia (Not Iron-Deficiency)

TC II deficiency presents with a completely different type of anemia—megaloblastic anemia due to intracellular cobalamin (vitamin B12) deficiency, not iron deficiency:

  • Megaloblastic anemia with pancytopenia is the hallmark presentation 5, 6
  • Early onset in infancy with failure to thrive, weakness, diarrhea, and pallor 6
  • May present with agammaglobulinemia or resemble severe combined immunodeficiency 6
  • Diagnosis confirmed by elevated homocysteine and methylmalonic acid, not iron studies 6

This is mechanistically distinct from iron-deficiency anemia. Megaloblastic anemia features macrocytic red blood cells (large MCV), whereas iron-deficiency anemia is microcytic (small MCV) 7.

Why These Are Not Related to Anemia of Chronic Disease

The provided guidelines on anemia of chronic disease 8 discuss conditions like:

  • Chronic kidney disease
  • Chronic heart failure
  • Inflammatory bowel disease

These involve hepcidin-mediated iron dysregulation and chronic inflammation—pathophysiologic mechanisms completely absent in both SCOT and TC II deficiencies.

Clinical Pitfall to Avoid

Do not confuse the megaloblastic anemia of TC II deficiency with iron-deficiency anemia. The MCV will guide you: TC II deficiency causes macrocytic anemia (high MCV), while iron deficiency causes microcytic anemia (low MCV) 7. SCOT deficiency should not trigger anemia workup unless there is a separate, unrelated cause.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.